nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antimicrobic newsletter, volume 1 index
|
|
|
1984 |
|
12 |
p. 99- 1 p. |
artikel |
2 |
Editor's note
|
|
|
1992 |
|
12 |
p. 75- 1 p. |
artikel |
3 |
Editor's note
|
|
|
1989 |
|
12 |
p. 93- 1 p. |
artikel |
4 |
Editor's note
|
|
|
1984 |
|
12 |
p. 93- 1 p. |
artikel |
5 |
Editor's note
|
|
|
1985 |
|
12 |
p. 85- 1 p. |
artikel |
6 |
Editor's note
|
|
|
1987 |
|
12 |
p. 101- 1 p. |
artikel |
7 |
Editor's note
|
|
|
1986 |
|
12 |
p. 87- 1 p. |
artikel |
8 |
Fluoroquinolone-drug interactions: An overview
|
Prince, Randall A. |
|
1989 |
|
12 |
p. 93-98 6 p. |
artikel |
9 |
Historical overview of the cephalosporin spectrum: Four generations of structural evolution
|
Sader, Helio S. |
|
1992 |
|
12 |
p. 75-82 8 p. |
artikel |
10 |
Index to volume 8
|
|
|
1992 |
|
12 |
p. 82-83 2 p. |
artikel |
11 |
In vitro technical comment: Branhamella catarrhalis assessing beta-lactamase production
|
Amsterdam, D. |
|
1986 |
|
12 |
p. 89-90 2 p. |
artikel |
12 |
NCCLS subcommittee members respond
|
Allan Waitz, J. |
|
1987 |
|
12 |
p. 101-105 5 p. |
artikel |
13 |
New drugs, Part II
|
Jones, Ronald N. |
|
1986 |
|
12 |
p. 87-89 3 p. |
artikel |
14 |
Standards and advisory activities
|
Allan Waitz, J. |
|
1987 |
|
12 |
p. 105-106 2 p. |
artikel |
15 |
The antimicrobic newsletter, volume 4, 1987 index
|
|
|
1987 |
|
12 |
p. 106-108 3 p. |
artikel |
16 |
The antimicrobic newsletter, volume 6, 1989 index
|
|
|
1989 |
|
12 |
p. 98-99 2 p. |
artikel |
17 |
The impact of proficiency survey programs on laboratory antimicrobial susceptibility testing
|
Fuchs, P.C. |
|
1984 |
|
12 |
p. 93-98 6 p. |
artikel |
18 |
The rapidly growing mycobacteria: Characterization and susceptibility testing
|
Wallace Jr., Richard J |
|
1985 |
|
12 |
p. 85-92 8 p. |
artikel |
19 |
Volume 3 index
|
|
|
1986 |
|
12 |
p. 91-92 2 p. |
artikel |